Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfeeder.co
Get the latest updates from AZ - Early R&D directly as they happen.
Follow now < 10 followers
Last updated about 1 hour ago
about 2 hours ago
Conditions: Acute Leukemia of Ambiguous Lineage; B Acute Lymphoblastic Leukemia; B Acute...
about 22 hours ago
Conditions: MTAP-deleted Solid Tumors Interventions: Drug: BAY 3713372 Sponsors: Bayer Recruiting
about 22 hours ago
Conditions: Acute Myeloid Leukemia Sponsors: University of Freiburg Recruiting
1 day ago
FHD-909, a selective SMARCA2 inhibitor for NSCLC, is nearing a key expansion...
1 day ago
FHD-909, a selective SMARCA2 inhibitor, is the lead focus with a pivotal...
2 days ago
Conditions: Acute Leukemia of Ambiguous Lineage; B Acute Lymphoblastic Leukemia; B Acute...
3 days ago
Conditions: Acute Leukemia Interventions: Drug: Bleximenib Sponsors: Janssen Research & Development, LLC...
3 days ago
Conditions: NSCLC Adenocarcinoma; Gastroesophageal Cancer (GC); Gastric Adenocarcinoma; Adenocarcinoma of Esophagus; Squamous...
3 days ago
Conditions: Advanced Solid Tumors With Homozygous MTAP Deletion Interventions: Drug: BMS-986504; Drug...
3 days ago
Conditions: NSCLC Adenocarcinoma; Gastroesophageal Cancer (GC); Gastric Adenocarcinoma; Adenocarcinoma of Esophagus; Squamous...
3 days ago
Conditions: Advanced Non-Small Cell Lung Cancer; Metastatic Non-Small Cell Lung Cancer Interventions...
7 days ago
Conditions: AML With NPM1 Mutations or KMT2A Rearrangements Sponsors: University of Freiburg...